On February 10, 2025, the Company announced its plans to acquire Kito Crosby, a combination that we believe will bring ...
A Q&A with Amyn Hassanally, a partner and global head of private equity secondaries at Pantheon, to find out if GP-led CVs ...
During the 109th Legislature’s 60-day 2026 session, The Star-Herald is offering this ongoing summary of Unicameral actions on ...
Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...